CVS HEALTH Corp (CVS)
Retail-Drug Stores and Proprietary Stores
Latest Price
$104.43
TTM P/E
45.80
Normalized P/E
25.93
Div Yield
2.55%
Book Value
60.85
P/B Ratio
1.72
Valuation metrics
adjust assumptions →EPS: $1.39
Book value / share: $59.18
Formula: √(22.5 × EPS × BVPS)
Graham Number
$43.02
59% downside
Norm. op. income: $12.0B (median of 7yr)
Tax rate: 25%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$31.23
70% downside
Base FCF: $10.4B (median of recent 5yr)
Growth: 1%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$67.29
36% downside
EPS: $1.39
Target P/E: 26×
Formula: EPS × P/E
P/E Fair Value
$36.14
65% downside
Institutional Ownership
83.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 125.92M | $9.04B | 9.89% | +4.93M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 82.65M | $5.93B | 6.49% | -- | 2026-03-31 |
| Capital World Investors | 77.25M | $5.55B | 6.07% | +9.59M | 2026-03-31 |
| STATE STREET CORP | 59.32M | $4.26B | 4.66% | -861.6K | 2026-03-31 |
| Dodge & Cox | 51.78M | $3.72B | 4.07% | -10.73M | 2026-03-31 |
| FMR LLC | 31.20M | $2.24B | 2.45% | -9.82M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 29.46M | $2.11B | 2.31% | +418.8K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 26.00M | $1.87B | 2.04% | -- | 2026-03-31 |
| Invesco Ltd. | 25.14M | $1.80B | 1.97% | +1.12M | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 23.78M | $1.71B | 1.87% | +7.34M | 2026-03-31 |